Global Neurological Disorder Diagnostics Market to Reach $16.6 Billion by 2029, Growing at 7.1% CAGR

"What Is the Expected Size and Growth Rate of the Neurological Disorder Diagnostics Market?
In recent times, the market size of neurological disorder diagnostics has experienced robust growth. Its size is anticipated to increase from $11.75 billion in 2024 to $12.61 billion in 2025, with a compound annual growth rate (CAGR) of 7.3%. Factors that have contributed to growth in the historical period include a rising prevalence of neurological disorders, an aging population, increased focus on early detection and management of the disease, heightened awareness of neurological disorders, and enhanced efforts towards early diagnosis.

In the upcoming years, the neurological disorder diagnostics market is projected to experience robust growth, with its size predicted to reach $16.6 billion by 2029, reflecting a compound annual growth rate (CAGR) of 7.1%. This growth during the forecast period is likely to result from rising awareness and education, larger healthcare spending, enhanced healthcare service accessibility, the proliferation of diagnostic centers, and the growing embrace of personalized medicine. Key trends during this period encompass progress in neuroimaging techniques, the adoption of wearable devices and remote surveillance technologies, breakthroughs in biomarker discovery and genetic testing, the incorporation of artificial intelligence and machine learning, as well as the launch of point-of-care diagnostic equipment.

What Factors Are Fueling Growth in the Neurological Disorder Diagnostics Market?
The expected rise in Alzheimer's disease cases will likely drive the expansion of the neurological disorder diagnostics market. Alzheimer's disease, a degenerative neurological disorder, progressively affects cognitive functions such as memory, reasoning, and problem-solving. This disease results from a cocktail of genetic elements, including specific gene mutations and variations, besides the buildup of amyloid plaques and tau tangles in the brain. Other influencing factors include chronic inflammation, vascular issues, and lifestyle factors. Neurological disorder diagnostics can facilitate early and precise detection of Alzheimer's using sophisticated imaging techniques, biomarker analysis, and cognitive evaluations. As an example, the Australian Institute of Health and Welfare, a government agency based in Australia, reported that in 2023, around 411,100 individuals, including roughly 257,500 women and 153,700 men, were affected by dementia in Australia. Hence, the anticipated increase in Alzheimer's disease cases is set to boost the neurological disorder diagnostics market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19611&type=smp

Which Leading Companies Are Shaping the Growth of the Neurological Disorder Diagnostics Market?
Major companies operating in the neurological disorder diagnostics market are Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Novartis AG, Medtronic plc, Amgen Inc., Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Otsuka Pharmaceutical Co. Ltd., Boston Scientific Corporation, Neurocrine Biosciences Inc., Neusoft Medical Systems Co. Ltd., Nihon Kohden Corporation, Natus Medical Incorporated, Esaote S.p.A, Canon Medical Systems Corporation, NeuroPace Inc., Lifelines Neuro Company LLC, York Instruments Ltd., Advanced Brain Monitoring Inc., Neurometrix Inc., Croton Healthcare Private Limited, NeuroLogica Corporation

What Are the Major Trends Shaping the Neurological Disorder Diagnostics Market?
Leading firms in the neurological disorder diagnostics market are concentrating on the creation of innovative solutions, such as neurological ailment quantification software, intended to serve one billion people worldwide living with neurological conditions. Neurological ailment quantification software is a solution that enables the tracking and analysis of brain activity and disease progression in neurological disorders. For example, in January 2024, Quibim, a biotechnology company based in Spain, debuted QP-Brain, a groundbreaking AI-powered tool engineered for early-stage neurological disorder quantification. The QP-Brain software from Quibim provides an advanced neuroimaging analysis platform capable of quantifying changes in brain tissue related to neurological conditions. Its distinct attributes consist of AI-driven automatic segmentation and comprehensive volumetric evaluation, providing accurate perspectives on alterations in brain structure for both clinical and investigative purposes.

What Are the Key Segments of the Neurological Disorder Diagnostics Market?
The neurological disorder diagnosticsmarket covered in this report is segmented -

1) By Component: Instruments, Reagents, Kits, Software, Services
2) By Technology: Immunoassay, Polymerase Chain Reaction (PCR) Techniques
3) By Disease Type: Alzheimer's Disease, Dementia, Parkinson's Disease, Epilepsy, Traumatic Brain Injury, Other Disease Types
4) By End User: Hospitals And Clinics, Diagnostic Centers, Academic And Research Institutes

Subsegments:
1) By Instruments: Electroencephalography (EEG) Machines, Magnetic Resonance Imaging (MRI) Machines, Computed Tomography (CT) Scanners, Positron Emission Tomography (PET) Scanners, Lumbar Puncture Equipment, Ultrasound Devices, Neurostimulation Devices, Transcranial Magnetic Stimulation (TMS) Devices,
2) By Reagents: Biochemical Reagents, Antibodies, DNA Probes, RNA Probes, Enzyme-linked Immunosorbent Assay (ELISA) Reagents, Polymerase Chain Reaction (PCR) Reagents, Sample Collection Reagents
3) By Kits: Diagnostic Test Kits, Genetic Testing Kits, Biomarker Detection Kits, Immunoassay Kits, Point-of-Care Testing Kits, Screening Kits for Neurological Disorders
4) By Software: Diagnostic Software for Imaging Analysis, Data Management Software, Clinical Decision Support Software, Patient Management Software, Laboratory Information Management Systems (LIMS), Neuroinformatics Software, Telemedicine Software
5) By Services: Diagnostic Testing Services, Consultation Services, Training and Support Services, Maintenance and Repair Services for Equipment, Telehealth Services, Data Analysis Services, Research and Development Services

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/neurological-disorder-diagnostics-global-market-report

Which Region Dominates the Neurological Disorder Diagnostics Market?
North America was the largest region in the neurological disorder diagnostics market in 2024. The regions covered in the neurological disorder diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Neurological Disorder Diagnostics Global Market Report?

- Market Size Analysis: Analyze the Neurological Disorder Diagnostics Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Neurological Disorder Diagnostics Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Neurological Disorder Diagnostics Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Neurological Disorder Diagnostics Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19611

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.